Novartis Investigative Site

Sabinov 08301

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), Spondylitis, Ankylosing

Studies at this site

• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis — Completed